Stanford University

Stanford University is a private research university whose School of Medicine has conducted and published work on ibogaine in the context of traumatic brain injury and post-traumatic stress in military veterans. Researchers there reported observational findings from a cohort of special-operations veterans who traveled outside the United States for ibogaine treatment accompanied by intravenous magnesium, with assessments carried out before and after treatment under an academic protocol and institutional review. The resulting peer-reviewed publication is among the most widely cited contemporary academic sources on ibogaine and is referenced across the research and policy discussion covered on this wiki. Stanford investigators have also spoken publicly about the cardiac risks associated with ibogaine and about the regulatory constraints that prevent administration of the compound inside the United States, where it is a Schedule I substance. The university's role in the field is that of an academic research institution rather than a treatment provider: it does not administer ibogaine, and its published work is observational rather than a controlled clinical trial. Its involvement has affected the field mainly by moving ibogaine research into mainstream medical literature, by shaping how legislators and journalists describe the current evidence base, and by informing subsequent proposals for state-funded clinical research in the United States.